Systematic development of self-emulsifying drug delivery systems of atorvastatin with improved bioavailability potential

Scientia Pharmaceutica

Volumn 80, Issue 4, 2012, Pages 1027-1043

  Khan, Fariba ^a   Islam, Md Saiful ^b   Roni, Monzurul Amin ^c   Jalil, Reza Ul ^b  

^a UNIVERSITY OF ASIA PACIFIC   (Bangladesh)

^b UNIVERSITY OF DHAKA   (Bangladesh)

^c STATE UNIVERSITY OF BANGLADESH   (Bangladesh)

Author keywords

Atorvastatin; Oleic acid; Polyethyleneglycol 400; Self emulsifying drug delivery systems; Tween 80

Indexed keywords

ATORVASTATIN; COSURFACTANT; MACROGOL 400; OLEIC ACID; POLYSORBATE 80; SURFACTANT;

ARTICLE; COLOR; DROPLET SIZE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG STABILITY; EXCIPIENT; MICROEMULSION; PHYSICAL PARAMETERS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SELF EMULSIFYING DRUG DELIVERY SYSTEM; TURBIDITY; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 84870939206     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1201-06     Document Type: Article

References (32)

1. Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 1995; 12: 1561-1572. http://dx.doi.org/10.1023/A:1016268311867
2. Kim HJ, Yoon KA, Hahn M, Park ES, Chi SC. Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Dev Ind Pharm. 2000; 26: 523-529. http://dx.doi.org/10.1081/DDC-100101263
3. Kang BK, Lee JS, Chona SK, Jeong SY, Yuk SH, Khang G, Lee HB, Cho SH. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm. 2004; 274: 65-73. http://dx.doi.org/10.1016/j.ijpharm.2003.12.028
4. Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW. Self-emulsifying drug delivery systems (SEDDS) with polyglycolysed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm. 1994; 106: 15-23. http://dx.doi.org/10.1016/0378-5173(94)90271-2
5. Charman SA, Charman WN, Rogge MC, Wilson TD, Dutko FJ, Pouton CW. Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res. 1992; 9: 87-93. http://dx.doi.org/10.1023/A:1018987928936.
6. Kommuru TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm. 2001; 212: 233-246. http://dx.doi.org/10.1016/S0378-5173(00)00614-1
7. Kim MS, Jin SJ, Kim JS, Park HJ, Song HS, Neubert RHH, Hwang SJ. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanodroplets using supercritical antisolvent (SAS) process. Eur J Pharm Biopharm. 2008; 69: 454-465. http://dx.doi.org/10.1016/j.ejpb.2008.01.007
8. Corsini A, Bellosta S, Baetta R, Fumagalli R, Paoletti R, Bernini F. New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol Ther. 1999; 84: 413-428. http://dx.doi.org/10.1016/S0163-7258(99)00045-5
9. Kadu PJ, Kushare SS, Thacker DD, Gattani SG. Enhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems (SEDDS). Pharm Dev Technol. 2011; 16: 65-74. http://dx.doi.org/10.3109/10837450903499333.
10. Chouksey R, Pandey H, Jain AK, Soni H, Saraogi GK. Preparation and evaluation of the self-emulsifying drug delivery system containing atorvastatin HMG-CoA inhibiter. Int J Pharm Pharm Sci. 2011; 3: 147-152.
11. Shen HR, Zhong MK. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. J Pharm Pharmacol. 2006; 58: 1183-1191. http://dx.doi.org/10.1211/jpp.58.9.0004
12. Talegaonkar S, Mustafa G, Akhter S, Iqbal ZI. Design and Development of Oral Oil-in-Water Nanoemulsion Formulation Bearing Atorvastatin: In Vitro Assessment. J Disper Sci Tech. 2010; 31: 690-701. http://dx.doi.org/10.1080/01932690903120540.
13. Boza A, De la Cruz Y, Jordan G, Jauregui-Haza U, Aleman A, Caraballo I. Statistical optimization of a sustained-release matrix tablet of lobenzarit disodium. Drug Dev Ind Pharm. 2000; 26: 1303-1307. http://dx.doi.org/10.1081/DDC-100102313
14. Box GEP, Wilson KB. On the experimental attainment of optimum multifactorial conditions. Royal Stat Soc. 1951; 13: 1-12.
15. Singh SK, Dodge J, Durrani MJ, Khan MA. Optimization and characterization of controlled release pellets coated with experimental latex: I. Anionic drug. Int J Pharm. 1995; 125: 243-255. http://dx.doi.org/10.1016/0378-5173(95)00135-6
16. Sánchez-Lafuente C, Furlanetto S, Fernández-Arévalo M, Alvarez-Fuentes J, Rabasco AM, Faucci MT, Pinzauti S, Mura P. Didanosine extended-release matrix tablets: optimization of formulation variables using statistical experimental design. Int J Pharm. 2002; 237: 107-118. http://dx.doi.org/10.1016/S0378-5173(02)00028-5
17. Singh B, Kapil R, Nandi M, Ahuja N. Developing Oral Delivery Systems using Formulation by Design (FbD): Vital Precepts, Retrospect and Prospects. Exp Opin Drug Deliv. 2011; 8: 1341-1360. http://dx.doi.org/10.1517/17425247.2011.605120
18. Rawat M, Saraf S, Saraf S. Influence of Selected Formulation Variables on the Preparation of Enzyme-entrapped Eudragit S100 Microspheres. AAPS PharmSciTech: 2007; 8: E116. http://dx.doi.org/10.1208/pt0804116
19. Patil P, Joshi P, Paradkar A. Effect of Formulation Variables on Preparation and Evaluation of Gelled Self-emulsifying Drug Delivery Systems (SEDDS) of Ketoprofen. AAPS PharmSciTech: 2004; 5: 42. http://dx.doi.org/10.1208/pt050342
20. Schulman JH, Montagne JB. Formation of microemulsions by amino alkyl alcohols. Ann N Y Acad Sci. 1961; 92: 366-371. http://dx.doi.org/10.1111/j.1749-6632.1961.tb44987.
21. Mei X, Etzler FM, Wang Z. Use of texture analysis to study hydrophilic solvent effects on the mechanical properties of hard gelatin capsules. Int J Pharm. 2006; 324: 128-135. http://dx.doi.org/10.1016/j.ijpharm.2006.06.017.
22. Subramanian N, Ray S, Ghosal SK, Bhadra R, Moulik SP. Formulation Design of Self-Microemulsifying Drug Delivery Systems for Improved Oral Bioavailability of Celecoxib. Biol Pharm Bull. 2004; 27: 1993-1999. http://dx.doi.org/10.1248/bpb.27.1993
23. Karim A, Gokhale R, Cole M, Sherman J, Yeramian P, Bryant M, Franke H. HIV protease inhibitor SC-52151: a novel method of optimizing bioavailability profile via microemulsion drug delivery systems. Pharm Res. 1994; 11: S368.
24. Kibbe AH. Handbook of Pharmaceutical Excipients. 2000; 3rd Ed.
25. Groves MJ. The self-emulsifying action of mixed surfactants in oil. Acta Pharm Suec. 1976; 13: 361-372. http://www.ncbi.nlm.nih.gov/pubmed/998277
26. Patel AR, Vavia PR. Preparation and In vivo Evaluation of SMEDDS (Self-microemulsifying Drug Delivery Systems) Containing Fenofibrate. The AAPS J. 2007; 9: 41. http://dx.doi.org/10.1208/aapsj0903041.
27. Ayalon A, Levinger M, Roytblat S, Niddam V, Lifshitz R, Aronhime J. Patent application title: Polymorphic form of atorvastatin calcium. Publication date: 2008-11-20, Patent application number: 20080287691, IPC8 Class: AC07D20734FI; USPC Class: 548537.
28. Wankhede SV, Krishnaprasad M, Manjunath SY, Debnath S. Formulation and Stabilization of Atorvastatin Tablets. J Chem Pharm Res. 2010; 2: 548-554.
29. Shah DA, Bhatt KK, Mehta RS, Baldania SL, Gandhi TR. Stability indicating RP-HPLC estimation of atorvastatin calcium and amlodipine besylate in pharmaceutical formulations. Indian J Pharm Sci: 2008; 70: 754-760. http://dx.doi.org/10.4103/0250-474X.49117
30. Rajasekaran A, Sasikumar R, Dharuman J. Simultaneous RP-HPLC method for the stress degradation studies of atorvastatin calcium and ezetimibe in multicomponent dosage form. Ars Pharm. 2011; 52: 12-18.
31. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004; 58: 173-182. http://dx.doi.org/10.1016/j.biopha.2004.02.001.
32. Levy, MY, Benita S. Drug release from submicronized o/w emulsion: a new in vitro kinetic evaluation model. Int J Pharm. 1990; 66: 29-37. http://dx.doi.org/10.1016/0378-5173(90)90381-D